Bone Biologics Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 09/02/2026 | 23.88 K | $32.71 K | 100.00% | 1.33% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.95 K | $2.68 K | -52.67% | 0.11% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 230 | $315 | 0.00% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bone Biologics Corp institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Bone Biologics Corp. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 23,879
Tower Research Capital LLC (TRC): 1,953
SBI Securities Co., Ltd.: 230
UBS Group AG: 0
CLEAR STREET LLC: 138
1.45% of Bone Biologics Corp stock is owned by institutional investors.
Institutional investors have bought a total of 26.20 K shares in the last 24 months. This purchase volume represents approximately $33.01 K in transactions.